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The ketogenic diet (KD) has been utilized as a dietary therapeutic for nearly a century. One
experimental model particularly responsive to the KD is the BTBRT+tf/j (BTBR) mouse,
which displays phenotypic characteristics of autism spectrum disorder (ASD) and insulin
resistance. Recently, the study of impaired mitochondrial function has become a focal
point of research investigating the pathophysiology of ASD. As highly dynamic organelles,
mitochondria undergo constant fluctuations in morphology, biogenesis, and quality
control in order to maintain cellular homeostasis. An important modifier of mitochondrial
dynamics is energy availability. Therefore, the aim of this study was to examine the
impact of a KD on mitochondrial dynamics in the liver and brain (prefrontal cortex) of
the BTBR mouse model of ASD. Juvenile male C57Bl/6 (B6) and BTBR mice were
age-matched to 5 weeks of age before being fed standard chow (CD, 13% kcal fat)
or a KD (75% kcal fat) for 10–14 days. Analysis of brain tissue identified differences
in mitochondrial gene expression but no correlation with protein levels. Unlike in the
brain, KD led to decreased levels of mitochondrial proteins in the liver, despite increased
gene expression. Consistent with decreased mitochondrial proteins, we also observed
decreased mtDNA for all mice on the KD, demonstrating that the KD reduces the
total amount of mitochondria in the liver. In order to explain the discrepancy between
protein levels and gene expression, we investigated whether mitochondrial turnover via
mitophagy was increased. To this end, we examined expression levels of the mitophagy
regulator BNIP3 (BCL2/adenovirus E1B 19 kd-interacting protein 3). BNIP3 gene and
protein expression were significantly elevated in liver of KD animals (p < 0.05), indicating
the potential activation of mitophagy. Therefore, consumption of a KD exerts highly
tissue-specific effects, ultimately increasing mitochondrial turnover in the liver, while gene
and protein expression in the brain remaining tightly regulated.
Keywords: ketogenic diet, nutrient sensing, mitochondrial dynamics, mitochondrial respiration, liver metabolism,
mitochondrial fission, mitochondrial fusion
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INTRODUCTION
The ketogenic diet (KD) has been utilized as a dietary therapy in
clinical settings since the early 1920’s and is well-documented in
mitigating symptoms for a number of diseases, including epilepsy
(Rho, 2015), autism spectrum disorder (ASD; Ruskin et al., 2013),
and diabetes (Feinman et al., 2014). Mechanistically, the KD
functions to minimize carbohydrate availability and favor fatty
acid oxidation. Ketone bodies, the by-product of this metabolic
shift, are synthesized in the liver and ultimately consumed by
major organ systems such as the brain, heart, and skeletal muscle
as a major fuel source (Kossoff et al., 2009). Although the
mechanisms of ketone body generation and utilization are well-
understood, the tissue-specific impact of KD metabolism has yet
to be examined.
Responsible for a host of metabolic processes including
cellular bioenergetics and energy balance regulation,
mitochondria represent the metabolic endpoint for dietary
foodstuffs. As the principal site of fatty acid metabolism
through β-oxidation, assessment of mitochondrial function
through oxidative phosphorylation (OXPHOS) efficiency is
a primary measure in KD interventions (Gano et al., 2014;
Vidali et al., 2015). However, the literature primarily focuses
on the relationship between the KD and brain tissue (Veech,
2004; Masino and Rho, 2012; Milder and Patel, 2012), failing to
examine the tissue responsible for ketogenesis—the liver.
In addition to their role in metabolism, mitochondria
are known to exist as dynamic organelles. The study of
mitochondrial dynamics refers to a group of specialized
processes governing mitochondrial morphology, biogenesis,
movement, and quality control (Ni et al., 2015; Wai et al.,
2016). Mitochondrial morphology can be divided into two
aspects: fission (fragmentation) and fusion (elongation). Many
proteins and pathways are implicated in mitochondrial fission
and fusion although the main regulators of fission are the
proteins; dynamin-related protein 1 (DRP1), mitochondrial
fission 1 protein (FIS1), mitochondrial fission factor (MFF) and
mitochondrial dynamics proteins of 49 and 51 kDa (MiD49/51),
whereas fusion is primarily regulated by the proteins; mitofusin
1 & 2 (MFN1, MFN2) and optic atrophy 1 (OPA1; Okamoto
and Shaw, 2005; Chan, 2006; Detmer and Chan, 2007; Losón
et al., 2013; Hoppins, 2014). Recently, peroxisome proliferator-
activated receptor-γ coactivator 1-α (PGC-1α) has emerged as
a potential upstream regulator of fission and fusion machinery.
PGC-1α governs mitochondrial biogenesis (Dabrowska et al.,
2015) and acts by regulating mitochondrial protein translation in
response to energy balance fluctuations. Furthermore, variations
in nutrient availability can also trigger mitochondrial movement
within the cell (Ahmad et al., 2014).
Another important aspect of mitochondrial dynamics
is quality control. Termed mitophagy, this mechanism is
responsible for the selective lysosome-dependent autophagy
of mitochondria (Zhang, 2013). Through the breakdown of
dysfunctional mitochondria, mitophagy helps to maintain
mitochondrial homeostasis within the cell (Youle and Narendra,
2011). Mitophagy inducing receptors are present on the outer
mitochondrial membrane and facilitate lysosomal degradation
of mitochondria by localizing microtubule-associated protein
1A/1B-light chain 3 to the outer mitochondrial membrane
(Tanida et al., 2008). A common mitophagy regulator is
BCL2/adenovirus E1B 19 kd-interacting protein 3 (BNIP3;
Ney, 2015). Once triggered, BNIP3 migrates to the outer
mitochondrial membrane and is responsible for inducing
mitophagy under conditions of cell stress, including hypoxia
(Zhang et al., 2008) and fasting (Glick et al., 2012). Interestingly,
the KD acts by metabolically mimicking the fasted state and
mitophagy regulation has yet to be examined following this
therapy.
To this end, we examined the impact of the KD on
mitochondrial dynamics in the liver and brain (prefrontal cortex)
using twomouse genotypes, the C57Bl/6 (B6) and the BTBRT+tf/j
(BTBR). The BTBR mouse was chosen as it has been widely
utilized as a model of ASD (Meyza et al., 2013; Newell et al.,
2016) and insulin resistance (Stoehr et al., 2000), as well as
exhibiting behavioral alterations (Ruskin et al., 2013). Moreover,
the KD has recently been shown to alter the metabolome and
microbiome of BTBR animals, which are strongly correlated with
host metabolic function (Klein et al., 2016; Newell et al., 2016).
We hypothesized that the metabolic shift initiated by the KD
would involve alterations in the expression of proteins governing
mitochondrial dynamics in both the liver and brain.
MATERIALS AND METHODS
Animals and Dietary Interventions
All experimental protocols for this study were completed under
the ethics report (A13-0313) approved by the University of
Calgary Animal Care and Use Committee, as well as guidelines
established by the Canadian Council on Animal Care. Juvenile
male C57Bl/6 (B6) and BTBR mice (n = 21 and 25, respectively)
were separated by genotype and housed 4–6 per cage. Animals
were age-matched to 5 weeks of age before being randomly
selected for implementation of a standard chow (CD; 13%
kcal fat) or ketogenic diet (KD; 75% kcal fat; Bio-Serv F3666,
Frenchtown, USA). This resulted in four treatment groups:
B6-Chow, B6-Ketogenic, BTBR-Chow, and BTBR-Ketogenic
(n = 11, 10, 15, and 10, respectively). Prior to sacrifice,
animals were housed in a humidity-controlled room with a
12-h light/dark Zeitgeber cycle and were fed ad libitum. After
10–14 days of dietary intervention mice were weighed and
whole blood was analyzed for glucose and circulating ketone
bodies (β-hydroxybutyrate) with Precision Xtra meters (Abbott
Laboratories, Alameda, USA) before being sacrificed by cervical
dislocation. Liver, brain (prefrontal cortex), and whole blood
were removed and either kept fresh or flash-frozen and stored
at−80◦C until later testing. At the time of sacrifice, animals were
6 weeks of age.
Mitochondrial Respirometry
Fresh liver tissue from the upper left lobe was rinsed and
homogenized in mitochondrial isolation buffer [70 mM sucrose,
210 mM mannitol, 5 mM HEPES, 1 mM EGTA, and 0.5%
(w/v) fatty-acid free bovine serum albumin (BSA), pH 7.2
at 4◦C; Sigma-Aldrich, Oakville, Canada] before undergoing
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differential centrifugation, according to procedures modified
from a previously published report (Rogers et al., 2011). Protein
quantification of liver mitochondria was performed with BSA
as the standard using the Bradford method (Bio-Rad, Hercules,
USA). High-resolution, high-throughput respirometry measures
were performed on isolated mitochondrial samples using
the XFe24 Extracellular Flux Analyzer (Seahorse Bioscience,
Billerica, USA) as previously described (Rogers et al., 2011).
A total of 8 µg of liver mitochondria was used and each
sample was run in triplicate with results normalized to starting
protein concentration. Substrate additions were as follows (final
concentration): 4 mM ADP, 2 µg/mL oligomycin, 2 µM FCCP,
and 2 µM antimycin A (Sigma-Aldrich). Respiration buffer
contained 5 mM succinate and 2 µM rotenone (Sigma Aldrich)
in order to isolate mitochondrial respiration through Complex II
of the electron transport chain.
Citrate Synthase Enzyme Activity
Citrate synthase activity, a mitochondrial enzyme and marker of
mitochondrial content, was measured from liver homogenates
using a spectrophotometric method (Tweedie et al., 2011).
Enzyme activity was then normalized to starting protein
concentration.
RNA Extraction and qRT-PCR
Total ribonucleic acid (RNA) was extracted from 25mg of frozen
liver and brain tissues using the PureLink RNA Mini Kit (Life
Technologies, Burlington, Canada) and was measured using a
NanoDrop-1000 (Thermo Fisher Scientific, Burlington, Canada).
Reverse transcription was performed with 1 µg of RNA using
the iScript cDNA Synthesis Kit (Bio-Rad). cDNA products were
quantified using a NanoDrop-1000 (Thermo Fisher Scientific).
qRT-PCR was performed in 20 µl reaction volumes using 50 ng
of complimentary DNA (cDNA). Primer pairs were synthesized
by the University of Calgary Core DNA Services (Table S1).
The PCR conditions were as follows: 95◦C—2 min, 40 cycles of
(95◦C—30 s, 60◦C—30 s, 72◦C—30 s), 72◦C—2 min. Samples
were run in triplicate on the same reaction plate using the CFX96
Real-Time PCR Detection System (Bio-Rad) with β-actin as a
loading control. Data analysis was performed in accordance with
previously published work using the 2−11Ct method (Lee et al.,
2012).
Ratio of mtDNA/nDNA Copy Number
As surrogates for mitochondrial abundance through
measurements of relative mtDNA copy numbers, liver and
brain tissues were used to determine the mtDNA/nDNA ratio for
the mitochondrial genome-encoded cytochrome b (MT-CYB)
and NADH dehydrogenase 2 (ND2). The expression of these
genes was then expressed in relation to the nuclear-encoded
β-globin. The relative mtDNA copy number was measured
according to the method of Wong and Cortopassi (2002) and Liu
et al. (2003).
Protein Immunoblotting
Liver and brain tissues were homogenized in a lysis buffer
containing 20 mM NaCl, 20 mM Tris-HCl, 0.1 mM EDTA,
1% Triton X-100, 0.5% sodium deoxychloate, and 0.1% β-
mercaptoethanol along with a protease inhibitor cocktail
(Sigma-Aldrich) and a phosphatase inhibitor cocktail (Thermo
Fisher Scientific). Tissue homogenates then underwent protein
quantification with BSA as the standard using the Bradford
method (Bio-Rad). Liver and brain lysates in Laemmli buffer
were separated by SDS-PAGE. Samples were loaded onto
4–12% Bis-Tris SDS-polyacrylamide gels (Invitrogen) and
then transferred using gel electrophoresis to polyvinylidine
difluoride membranes (Millipore, Billerica, USA). Membranes
were probed with primary antibodies overnight at 4◦C on a
shaking platform and then incubated with secondary antibodies
for 1.5 h at room temperature. Primary antibodies were as
follows: DRP1 (catalog no. ab56788, Abcam, Cambridge, USA),
FIS1 (catalog no. sc-98900, Santa Cruz Biotechnologies, Dallas,
USA), MFF (catalog no. ab81127, Abcam), MFN1 (catalog no.
ab57602, Abcam), MFN2 (catalog no. ab101055, Abcam), OPA1
(catalog no. ab42364, Abcam), BNIP3 (catalog no. 3769, Cell
Signaling Technology, Whitby, Canada), PGC-1α (catalog no.
sc-13067, Santa Cruz), mitochondrial outer membrane protein—
voltage-dependent anion-selective channel 1 (VDAC1; catalog
no. ab15895, Abcam), Total OXPHOS (catalog no. ab110413,
Abcam), and β-actin (catalog no. ab8226, Abcam). Membranes
were exposed to the chemiluminescent SuperSignal West
Femto Maximum Sensitivity Substrate (Life Technologies) and
imaged using the ChemiGenius imaging system (Syngene,
Frederick, USA). Densitometry was performed using
GeneTools (Syngene) with β-Actin (Abcam) used as a loading
control.
Statistical Analyses
Statistical analysis was performed using IBM SPSS Statistics
for Windows, Version 21.0. Differences between the genotype
and diet were determined by a two-way analysis of variance
(ANOVA), followed by a Tukey’s post-hoc test where p < 0.05
was considered to be significant. Data are expressed as mean ±
SEM.
RESULTS
Animal Characteristics
Animal weight, blood glucose, and blood ketone levels are
reported in Table 1. Consuming the KD caused diet-dependent
reductions in body mass across both genotypes (p< 0.05). BTBR
mice also exhibited a greater body weight than B6 (p < 0.05).
Mice fed a KD resulted in significantly elevated circulating ketone
bodies and decreased blood glucose levels across both genotypes
(p < 0.05). Animal characteristics have been previously reported
(Klein et al., 2016), and they are included here to provide a frame
of reference for the mitochondrial function data in the BTBR
mouse.
Mitochondrial Function
A general schematic of experimental findings is shown in
Figure 1.
Liver mitochondrial respiration is described in Table 2.
ADP facilitated respiration (basal respiration) was lower in
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B6-Ketogenic mice compared to all other groups (p <
0.05). FCCP (maximal respiration) and oligomycin (proton
leak) mediated respiration decreased in B6 animals fed a
KD (p < 0.05). Antimycin A respiration (non-mitochondrial
respiration) showed no significant differences between either
dietary treatment or genotype (p > 0.05). There were
no differences in citrate synthase enzyme activity across
groups.
Protein Immunoblotting of Mitochondrial
OXPHOS Subunits
Protein levels of mitochondrial electron transport system
subunits are reported in Figure 2. Brain tissues demonstrated
no variation due to genotype or dietary intervention
(Figure 2B). However, KD fed mice had decreased
Complex II and Complex III protein expression in liver
(Figure 2A).
TABLE 1 | Animal characteristics.
B6 BTBR
Chow Ketogenic Chow Ketogenic
Mass (g) 18.4 ± 0.8* 10.5 ± 0.3 28.6 ± 1.3*† 15.9 ± 1.0†
Blood glucose (mmol/L) 10.4 ± 0.6* 4.3 ± 0.5 7.8 ± 0.3* 3.7 ± 0.5
Blood ketones (mmol/L) 0.9 ± 0.1 5.1 ± 0.8* 0.9 ± 0.1 5.1 ± 0.8*
Age-matched B6 and BTBR mice were sacrificed following 10–14 days of either standard
chow or ketogenic feeding. All characteristics were assessed prior to sacrifice. Data
represent mean ± SEM (B6-Chow, B6-Ketogenic, BTBR-Chow, and BTBR-Ketogenic;
n = 11, 10, 15, and 10, respectively). *Indicates a difference due to diet at p < 0.05.
†
Indicates a difference due to genotype at p < 0.05.
Mitochondrial Dynamics. Gene Expression
of Mitochondrial Morphology Regulators
(qRT-PCR)
The gene expression of key mitochondrial fission and fusion
mediators was examined in both the liver and brain (Figure 3).
KD consumption resulted in wide-spread increases in gene
expression across both genotypes. Both liver and brain tissues
had elevated expression of key fission (FIS1, DRP1, and MFF)
and/or fusion (MFN1, MFN2, and OPA1) genes following KD
(Figures 3A–D; p< 0.05).
TABLE 2 | Mitochondrial respirometry performed on mitochondria isolated
from liver tissue homogenates using an XFe24 Extracellular Flux Analyzer.
B6 BTBR
Chow Ketogenic Chow Ketogenic
ADP 202 ± 8.6* 139 ± 12 165 ± 24 150 ± 16
Oligomycin 79 ± 23* 37 ± 8.3 64 ± 10 56 ± 9.3
FCCP 215 ± 13*† 55 ± 14 174 ± 29 152 ± 19
Antimycin A 19 ± 10 17 ± 5.1 41 ± 15 18 ± 9.2
Citrate synthase activity 34 ± 1.0 35 ± 2.6 34 ± 1.4 36 ± 2.1
Age-matched B6 and BTBR mice were sacrificed following 10–14 days of either chow or
ketogenic diet feeding. Respiration buffer contained 5 mM succinate and 2 µM rotenone
in order to isolate mitochondrial respiration through Complex II of the electron transport
chain. Oxygen consumption rate was normalized to protein concentration, resulting in
each value expressed as pmoles/min/µgmitochondrial protein. Themitochondrial enzyme
citrate synthase is listed as a marker of mitochondrial abundance; each value is expressed
asµM/min/mg protein. Data represent themean±SEM (B6-Chow, B6-Ketogenic, BTBR-
Chow, and BTBR-Ketogenic; n= 11, 10, 15, and 10, respectively). *Indicates a difference
due to diet at p < 0.05.
†
Indicates a difference due to genotype at p < 0.05.
FIGURE 1 | Schematic of molecular pathways investigated in the present study. A summary of the tissue-specific findings related to mitochondrial function
and mitochondrial dynamics. ATP, adenosine triphosphate; BNIP3, BCL2/adenovirus E1B 19 kd-interacting protein 3; OXPHOS, oxidative phosphorylation; VDAC1,
voltage-dependent anion-selective channel 1.
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FIGURE 2 | Quantification of protein immunoblots for mitochondrial electron transport system subunits. Liver (A) and brain (B) tissues were analyzed for
protein expression of mitochondrial oxidative phosphorylation (OXPHOS) subunits (CI–V). All protein expression data was analyzed using β-Actin as a loading control.
All data are presented as mean ± SEM (B6-Chow, B6-Ketogenic, BTBR-Chow, and BTBR-Ketogenic; n = 8 for each). *Indicates a difference due to diet at p < 0.05.
Protein Immunoblotting of Mitochondrial
Morphology Regulators
Interestingly, no differences in protein expression for any of the
same key mitochondrial fission or fusion mediators was found
in brain (Figures 3F,H). In contrast, the protein expression for
these mitochondrial fission and fusion mediators in liver were
found to decrease following KD (Figures 3E,G). Specifically,
expression of the fission protein DRP1 and the fusion protein
MFN2 were decreased after KD treatment, while the remaining
proteins trended toward a decline after KD consumption.
Mitochondrial Abundance and Biogenesis
Expectedly, no changes in the mtDNA/nDNA copy number
ratio were detected in brain tissue (Figure 4B). By contrast,
dietary differences were identified within each genotype for
liver. BTBR mice consuming a KD resulted in a significant
decrease in the mtDNA/nDNA copy number ratio in the
liver (Figure 4A; p < 0.05). A similar diet-induced trend
was identified in B6 mice although this was not statistically
significant. Additionally, measurements of gene and protein
expression for mitochondrial biogenesis regulator—PGC-1α
and mitochondrial outer membrane protein—VDAC1, we
also performed. Once again, analysis of brain tissue proved
unremarkable (Figures 4D,F) with only protein expression of
VDAC1 being elevated in BTBR-Ketogenic mice when compared
to either B6 fed group. Liver tissue, however, yielded an
increase in PGC-1α gene expression following KD consumption
(Figure 4C; p< 0.05). Interestingly, protein expression for PGC-
1α was not responsive in a similar manner, and this correlated
with a significant decrease in VDAC1 protein expression for KD
mice (Figure 4E; p< 0.05).
Mitochondrial Quality Control (Mitophagy)
Examination of the mitophagy promoter, BNIP3, revealed
unremarkable gene and protein expression profiles in brain
(Figures 5B,D). Although gene expression of BNIP3 was elevated
in all groups when compared to B6-Chow (p < 0.05), no
differences in protein expression were identified. Comparatively,
analysis of liver tissue proved interesting as both gene and protein
expression were upregulated in B6 and BTBR mice following KD
treatment (Figures 5A,C; p< 0.05).
DISCUSSION
Previous work has shown that the KD modulates metabolic,
cognitive, and behavioral impairments in a number of disease
states (Evangeliou et al., 2003; Herbert and Buckley, 2013).
Although the mechanism(s) of action through which the KD
imparts its beneficial effects are yet to be elucidated, we sought
to examine the impact of the KD on mitochondrial dynamics
in B6 and BTBR mice, a model known to be highly responsive
to the KD (Ruskin et al., 2013). To this end, we examined
mitochondrial function and aspects of mitochondrial dynamics
in the liver and brain of B6 and BTBRmice fed either a CD or KD.
The major findings of this study are as follows: (1) KD feeding
results in unremarkable changes to mitochondrial function or
mitochondrial dynamics in the brain; (2) KD consumption spurs
alterations in mitochondrial function in liver tissue; (3) the KD
significantly changes gene and protein expression for regulators
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FIGURE 3 | Assessment of mitochondrial morphology regulators employing gene and protein expression. Liver and brain tissues were analyzed for gene
(qRT-PCR) and protein expression (protein immunoblotting) of key mitochondrial morphology mediators. (A) Mitochondrial fission gene expression measured in liver.
(B) Mitochondrial fission gene expression measured in brain. (C) Mitochondrial fusion gene expression measured in liver. (D) Mitochondrial fusion gene expression
measured in brain. (E) Expression of mitochondrial fission proteins measured in liver. (F) Expression of mitochondrial fission proteins measured in brain. (G) Expression
of mitochondrial fusion proteins measured in liver. (H) Expression of mitochondrial fusion proteins measured in brain. All gene expression data were collected using
qRT-PCR with β-Actin as a loading control. All protein expression data were analyzed using β-Actin as a loading control. All data are presented as mean ± SEM
(B6-Chow, B6-Ketogenic, BTBR-Chow, and BTBR-Ketogenic; n = 8 for each). *Indicates a difference due to diet at p < 0.05. † Indicates a difference due to genotype
at p < 0.05.
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FIGURE 4 | Evaluation of mitochondrial gene and protein expression to infer regulation of mitochondrial abundance and biogenesis. Liver and brain
tissues were analyzed to measure the mtDNA/nDNA ratios for the mitochondrial genome-encoded cytochrome b (MT-CYB) and NADH dehydrogenase 2 (ND2),
expressed relative to the nuclear-encoded β-globin. (A) mtDNA/nDNA ratio measured from liver. (B) mtDNA/nDNA ratio measured from brain. Liver and brain tissues
were also analyzed for gene and protein expression of the mitochondrial biogenesis regulator—peroxisome proliferator-activated receptor-γ coactivator 1-α (PGC-1α)
and the marker of mitochondrial abundance—voltage-dependent anion-selective channel 1 (VDAC1). (C) Gene expression of PGC-1α and VDAC1 measured in liver.
(D) Gene expression of PGC-1α and VDAC1 measured in brain. (E) Protein expression of PGC-1α and VDAC1 measured in liver. (F) Protein expression of PGC-1α
and VDAC1 measured in brain. All qRT-PCR data were collected with β-Actin as a loading control and are presented as mean ± SEM (B6-Chow, B6-Ketogenic,
BTBR-Chow, and BTBR-Ketogenic; n = 8 for each). *Indicates a difference compared to all other groups at p < 0.05. † Indicates a difference due to genotype at
p < 0.05.
of mitochondrial morphology, abundance, and biogenesis in the
liver; (4) the KD results in elevated gene and protein expression
of the mitophagy regulator BNIP3.
Responsible for β-oxidation of fatty acids, liver mitochondrial
function is crucial to healthy energy balance, and a pivotal
site of metabolism when consuming a KD. However, the vast
majority of existing literature on the KD has focused on the brain
due to its well-documented neurologic benefits (Veech, 2004;
Masino and Rho, 2012; Milder and Patel, 2012). Both liver and
brain tissues were therefore assayed formitochondrial respiratory
rates, although technical issues enabled data acquisition for only
liver. In order to focus on fatty acid metabolism involvement,
respiratory substrates succinate, and rotenone were used. This
allowed us to analyze mitochondrial bioenergetics of Complex
II (Schönfeld et al., 2010). Although a limitation of the
present work is the constraint in tissue availability, future
research also warrants respiration data for Complex I substrates.
Potentially leading to differences in mitochondrial function,
examination of mitochondrial OXPHOS protein levels was
performed. Although brain tissue showed no differences, the
liver of KD fed mice from both genotypes demonstrated lower
Complex II and Complex III mitochondrial protein expression
(Figure 2A). This reduction in KD animals is likely due to
hepatic fat accumulation, inefficient mitochondrial bioenergetics,
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FIGURE 5 | Determination of mitochondrial gene and protein expression for mitochondrial quality control regulator BNIP3. Liver and brain tissues were
analyzed for gene (qRT-PCR) and protein expression (protein immunoblotting) of the mitophagy promoter—BCL2/adenovirus E1B 19 kd-interacting protein 3 (BNIP3).
(A) Gene expression of BNIP3 measured in liver. (B) Gene expression of BNIP3 measured in brain. (C) Protein expression of BNIP3 measured in liver. (D) Protein
expression of BNIP3 measured in brain. All data were analyzed using β-Actin as a loading control and are presented as mean ± SEM (B6-Chow, B6-Ketogenic,
BTBR-Chow, and BTBR-Ketogenic; n = 8 for each). *Indicates a difference due to diet at p < 0.05. † Indicates a difference due to genotype at p < 0.05.
and insulin resistance. However, the effects on mitochondrial
respiration were only observed in B6 and not BTBR animals.
This is likely a result of “two hits,” or simultaneous metabolic
insults in the BTBR model. Originally studied as a model
of insulin resistance (Flowers et al., 2007), the BTBR mouse
demonstrates a tempered metabolic disturbance to the KD diet
rich in fatty acids compared to B6 mice. In its early stages, insulin
resistance results in augmented mitochondrial bioenergetics and
enzyme activity—but the continued insult having the opposite
effect and eventually led to impaired mitochondrial function
and dysregulated mitochondrial dynamics in the liver (Putti
et al., 2015). Therefore, there were likely early mitochondrial
adaptations in the BTBRmouse stemming from a pre-disposition
to insulin resistance and as a result, the impact of the KD on
mitochondrial respiration was less pronounced.
Through mimicking the fasted state, the KD induces
ketogenesis in the liver, with the resultant ketone bodies being
metabolized by the brain. As such, a unique relationship between
liver and brain metabolism exists during KD treatment. We
hypothesized that this shift in nutrient availability would impact
mitochondrial dynamics. Thus, we examined differences in
gene and protein expression in the regulation of mitochondrial
morphology. Existing research supports the notion that fission
gene expression is upregulated with nutrient availability
(Holmström et al., 2012; Jheng et al., 2012) and fusion genes
are upregulated with nutrient deficiency (Rambold et al., 2011).
Contrary to this, the present liver and brain data suggest a global
upregulation of fission and fusion genes when fed the KD. These
findings may be linked to tissue-specific metabolic fluctuations
resulting from the stress of excess liver β-oxidation and brain
ketone body metabolism with the KD. However, examination
of protein expression suggests no changes in brain and a global
downregulation in the liver following KD feeding. This indicates
a tissue specific sensitivity to changes in sources of energy. The
differences between gene and protein in brain are likely due to
the tight regulation of energy production, in order to maintain
normal brain function (Du et al., 2008). However, gene and
protein differences in liver allow for rapid metabolic adaptations
should carbohydrates become available. Unfortunately, literature
examining the role of the KD to impact mitochondrial dynamics
is limited. Interestingly, existing work using co-cultured cells
with ketone body supplementation in the growth medium
(Santra et al., 2004) and mtDNA deletor mice consuming a KD
for over 30 weeks (Ahola-Erkkila et al., 2010), have demonstrated
positive effects of the KD on host mitochondrial function.
However, stark differences in duration of diet and type of model
organism make it difficult to compare those results to the present
findings.
One explanation for the disparity between gene expression
and protein levels is increased turnover of mitochondria via
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mitophagy. Although microscopic evidence of differences in
mitochondrial mass and morphology are the current gold-
standard, tissues from this animal cohort were not prepared
at the time of sacrifice. Therefore, we first surveyed for
differences in mitochondrial abundance by comparing the ratio
of mtDNA/nDNA, which assesses the relative copy number
abundance and therefore infers the amount of mitochondria
present in a sample. No differences were detected in the brain;
conversely, the mtDNA/nDNA copy number was decreased
in the liver of KD mice, irrespective of genotype. In order
to confirm these findings, we then investigated gene and
protein expression for VDAC1—a commonly studied protein
to assess mitochondrial abundance (Fritz et al., 2013). Once
again there were no notable differences in the brain. In contrast,
VDAC1 protein expression was decreased by the KD in liver.
These findings explain, in part, the decreased Complex II and
Complex III OXPHOS protein levels in KD-fed liver tissue.
Decreases in mitochondrial abundance caused by dysfunctional
energy homeostasis have been linked to increased mitochondrial
turnover (Youle and Narendra, 2011). This may indicate why
the mitochondrial abundance in liver, whose energy balance is
affected, declines while the mitochondrial abundance in brain
remains unchanged.
In order to identify whether the KD impacts mitophagy
signaling in liver or brain, we assessed levels of BNIP3—a primary
mitophagy regulator. Not surprisingly, there were no differences
in BNIP3 levels noted in the in brain; however, BNIP3 protein
and gene expression were both elevated in liver of both genotypes
after KD consumption. These results suggest that upregulation
of BNIP3-induced mitophagy in the liver may succeed the KD
in order to sequester mitochondrial disturbances spurred by
impairments in energy balance. Initially identified as exclusively
pro-apoptotic, BNIP3-induced mitophagy actually lowers the
cell’s capacity to release cytochrome c and preserves cell viability
(Zhu et al., 2013). This provides a clear connection between the
decreases in mtDNA/nDNA copy number and both VDAC1 and
OXPHOS protein expression in liver. However, as mitophagy
involves a diverse number of proteins and other organelles, the
complexities of this process must be further studied in response
to the KD.
The KD has been shown to cause elevated PPARα—
the transcription factor responsible for regulating fatty acid
metabolism in the liver (Kimura et al., 2013), and PGC-1α—a
primary coactivator responsible for regulation of mitochondrial
biogenesis (Liang and Ward, 2006). During conditions of energy
deprivation, PPARα promotes the metabolic conversion of fatty
acids to ketone bodies through upregulation of β-oxidation
(Braissant et al., 1996). Activation of PPARα facilitates the
downstream upregulation of BNIP3, which is required to
prevent excess lipid accumulation in liver tissue (Glick et al.,
2012), culminating in increased mitophagy, and decreased
mitochondrial abundance. As the upstream coactivator of
PPARα, PGC-1α responds to physiologic and pathologic stimuli
by regulating energy metabolism. Previous work examining the
metabolic impact of the KD has shown that liver gene expression
of PGC-1α is elevated in mice consuming a KD, although protein
expression was not examined (Jornayvaz et al., 2010). Liver
tissues of KD mice in the present study also yield elevated gene
expression of PGC-1α, although no changes in protein levels
were found. Our data demonstrate that both B6 and BTBR mice
respond to the KD by increasing gene and protein expression
of mitophagy regulator BNIP3 in the liver. These findings are
consistent with decreased mtDNA levels, decreased VDAC1
levels and the increases in PGC-1α gene expression. Increasing
rates of mitophagy in the liver may also explain the discrepancy
between gene and protein levels of the mitochondrial dynamics
regulators investigated in the present study. As the metabolic
pathways involving PGC-1α and PPARα are vastly complex, the
specific roles of individual gene and protein alterations must
be delineated accordingly. This suggests that although PGC-1α
is a primary upstream regulator of both PPARα and BNIP3,
the mechanism of how the KD influences the regulation of
BNIP3-induced mitophagy involves various gene and protein
interactions, which in turn will require further studies into
mitochondrial morphology and dynamics.
In summary, this study provides novel information about
the relationship between the KD and two key tissues, the
liver and brain. Our results show that the brain experiences
no disturbances in mitochondrial dynamics, likely due to
tight regulation of gene and protein expression. However,
the liver withstands the burden of metabolizing the excess
lipids consumed during the KD and experiences widespread
changes in mitochondrial function and mitochondrial
dynamics. This acts as a pathway to provide energy and to
preserve brain function, which is supplied through ketone
body production by the KD. Given the involvement of
dysfunctional mitochondria in various disease states and the
use of the KD as a clinical intervention, understanding how
energy intake affects mitochondrial dynamics may lead to
insights into how the KD exerts its broad-spectrum clinical
benefits.
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